1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Diabetes Mellitus, Type 2 in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (60.00) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 1 (6.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asmann, YW; Basu, A; Mukhopadhyay, D; Nandy, D | 1 |
Cheng, L; Han, X; Shi, Y | 1 |
Dow, CS; Falcioni, G; Gabbianelli, R; Swoboda, B; Vince, FP | 1 |
Cheng, YS; Fan, WK; Fang, YH; Yan, SG; Yu, YW; Zhang, JP; Zheng, JF; Zhou, SX | 1 |
Antonopoulou, S; Demopoulos, CA; Fragopoulou, E; Karantonis, HC; Phenekos, C; Rementzis, J | 1 |
Antonopoulou, S; Fragopoulou, E; Ginis, A; Karantonis, HC; Mitsou, E; Mourelatos, A; Phenekos, C; Rementzis, J; Sitara, M | 1 |
Karjalainen, A; Linnaluoto, M; Oikarinen, AI; Puukka, R; Ryhänen, L; Salmela, PI; Ukkola, O | 1 |
Akbani, H; Gilani, AH; Jabbar, A; Jafri, A; Memon, RA; Saeed, SA; Saleem, S | 1 |
Castellino, P; DeFronzo, RA; Tuttle, KR | 1 |
Akkerman, JW; Banga, JD; de Graaf, JC; Erkelens, DW; Sixma, JJ; van Breugel, HH; Westerveld, HT | 1 |
Cominacini, L; Fratta Pasini, A; Garbin, U; Lo Cascio, V | 1 |
Armani, U; Carrubba, M; Leoncini, G; Piana, A; Signorello, MG | 1 |
DeFronzo, RA; Kudolo, GB | 1 |
Botitsi, E; Mavris, M; Phenekos, C; Siafaka-Kapadai, A; Trapali, M | 1 |
Hashimoto, T; Ishii, H; Nawata, H; Umeda, F | 1 |
3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Effect of fast-food Mediterranean-type diet on type 2 diabetics and healthy human subjects' platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Platelets; Body Weight; Diabetes Mellitus, Type 2; Diet; Diet, Mediterranean; Energy Intake; Food Analysis; Humans; Lipids; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Reference Values; Restaurants | 2006 |
Effect of traditional Greek Mediterranean meals on platelet aggregation in normal subjects and in patients with type 2 diabetes mellitus.
Topics: Adenosine Diphosphate; Adult; Aged; Arachidonic Acid; Diabetes Mellitus, Type 2; Diet, Mediterranean; Female; Greece; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Thrombin | 2006 |
Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM.
Topics: Adenosine Diphosphate; Analysis of Variance; Blood Glucose; Blood Platelets; Blood Viscosity; Collagen; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Eicosapentaenoic Acid; Endothelium, Vascular; Erythrocyte Deformability; Extracellular Matrix; Female; Humans; In Vitro Techniques; Lipoprotein(a); Male; Middle Aged; Platelet Activating Factor; Platelet Adhesiveness; Platelet Aggregation | 1993 |
12 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Role of AKT-glycogen synthase kinase axis in monocyte activation in human beings with and without type 2 diabetes.
Topics: Cell Line; Cell Movement; Diabetes Mellitus, Type 2; Endothelial Cells; Enzyme Activation; Female; Gene Knockout Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Male; Middle Aged; Models, Biological; Monocytes; Platelet Activating Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction | 2010 |
A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acetyl Coenzyme A; Animals; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Hypoglycemic Agents; Lysophosphatidylcholines; Male; Mice; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection | 2009 |
A new method to evaluate spontaneous platelet aggregation in type 2 diabetes by Cellfacts.
Topics: Adenosine Diphosphate; Antioxidants; Azepines; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Triazoles; Vitamin E | 2003 |
[Relationship between serum vWF and PAF in type 2 diabetic patients and diabetic nephropathy].
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Platelet Activating Factor; von Willebrand Factor | 2005 |
Improved metabolic control in patients with non-insulin-dependent diabetes mellitus is associated with a slower accumulation of glycation products in collagen.
Topics: Adult; Aged; Blood Glucose; Blood Glucose Self-Monitoring; Collagen; Diabetes Mellitus, Type 2; Fasting; Female; Follow-Up Studies; Fructosamine; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Patient Education as Topic; Platelet Activating Factor; Regression Analysis; Time Factors | 1995 |
Altered platelet activating factor metabolism in insulin dependent diabetes mellitus.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Humans; Lipoproteins; Phospholipases A; Platelet Activating Factor | 1995 |
Diabetic nephropathy.
Topics: Adrenergic beta-Antagonists; Aldehyde Reductase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Glucose; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diet, Protein-Restricted; Diuretics; Exercise; Glycosylation; Guanidines; Humans; Hypertension; Platelet Activating Factor; Rats; Somatostatin; Weight Loss | 1994 |
Increased levels of plasma ELAM-1, ICAM-1 and VCAM-1 in NIDDM: possible role of oxidized LDL.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; E-Selectin; Humans; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Platelet Activating Factor; Reference Values; Risk Factors; Vascular Cell Adhesion Molecule-1 | 1996 |
Hyperactivity and increased hydrogen peroxide formation in platelets of NIDDM patients.
Topics: Adenosine Diphosphate; Aged; beta-Thromboglobulin; Blood Platelets; Case-Control Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Free Radicals; Humans; Hydrogen Peroxide; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Risk Factors; Thrombin; Thrombosis | 1997 |
Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Kidney Function Tests; Mexican Americans; Middle Aged; Platelet Activating Factor; Proteinuria | 1999 |
Effect of gliclazide on platelet-activating factor-induced platelet aggregation in patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Analysis of Variance; Diabetes Mellitus, Type 2; Gliclazide; Humans; In Vitro Techniques; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Regression Analysis | 1992 |
Increased intracellular calcium mobilization in platelets from patients with type 2 (non-insulin-dependent) diabetes mellitus.
Topics: Analysis of Variance; Blood Glucose; Blood Platelets; Calcimycin; Calcium; Calcium Chloride; Diabetes Mellitus, Type 2; Egtazic Acid; Female; Glycated Hemoglobin; Humans; In Vitro Techniques; Kinetics; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Reference Values; Thrombin | 1991 |